https://legacy.ensysce.com/abstract/clinical-evaluation-of-pf614-a-novel-taap-prodrug-of-oxycodone-versus-oxycontin-in-a-multi-ascending-dose-study-with-a-bioequivalence-arm-in-healthy-volunteers/ 2024-06-11T12:16:42+00:00 https://legacy.ensysce.com/abstract/first-in-human-pharmacokinetics-safety-study-of-pf614-orally-activated-oxycodone-prodrug-3/ 2024-06-11T12:16:54+00:00 https://legacy.ensysce.com/abstract/development-of-an-extended-release-nafamostat-formulation-for-prescription-drug-overdose-protection/ 2024-06-11T12:17:22+00:00 https://legacy.ensysce.com/abstract/pf614-mpar-a-novel-trypsin-activated-abuse-protected-taap-extended-release-oxycodone-prodrug-with-overdose-protection-2/ 2024-06-11T12:17:42+00:00 https://legacy.ensysce.com/abstract/intranasal-and-oral-human-abuse-potential-hap-studies-with-pf614-a-novel-trypsin-activated-abuse-protected-taap-oxycodone-prodrug/ 2024-06-11T12:18:50+00:00 https://legacy.ensysce.com/abstract/pf614-mpar-a-novel-trypsin-activated-abuse-protected-taap-extended-release-oxycodone-prodrug-with-overdose-protection-in-symposium-on-severe-pain-next-generation-solutions-pf6/ 2024-06-11T12:19:01+00:00 https://legacy.ensysce.com/abstract/pf614-mpar-a-novel-trypsin-activated-abuse-protected-taap-extended-release-oxycodone-prodrug-with-overdose-protection/ 2024-06-11T12:19:15+00:00 https://legacy.ensysce.com/abstract/intranasal-and-oral-human-abuse-potential-hap-studies-with-pf614-a-novel-trypsin-activated-abuse-protected-taap-extended-release-oxycodone-prodrug/ 2024-06-11T12:19:21+00:00 https://legacy.ensysce.com/abstract/development-of-a-multi-pill-abuse-resistant-extended-release-formulation-to-prevent-opioid-overdose/ 2024-06-11T12:19:33+00:00 https://legacy.ensysce.com/abstract/intranasal-human-abuse-potential-of-pf614-a-novel-next-generation-trypsin-activated-abuse-protected-taap-opioid/ 2024-06-11T12:19:44+00:00 https://legacy.ensysce.com/abstract/mpar-a-chemical-approach-to-opioid-overdose-protection/ 2024-06-11T12:19:55+00:00 https://legacy.ensysce.com/abstract/the-next-generation-opioid-products-for-moderate-severe-pain/ 2024-06-11T12:20:42+00:00 https://legacy.ensysce.com/abstract/first-in-human-pharmacokinetics-safety-study-of-pf614-orally-activated-oxycodone-prodrug-2/ 2024-06-11T12:20:58+00:00 https://legacy.ensysce.com/abstract/first-in-human-pharmacokinetics-safety-study-of-pf614-orally-activated-oxycodone-prodrug/ 2024-06-11T12:21:09+00:00 https://legacy.ensysce.com/abstract/in-vitro-and-in-vivo-assessment-of-the-abuse-potential-of-pf614-a-novel-bio-md-prodrug-of-oxycodone/ 2024-06-11T12:21:34+00:00 https://legacy.ensysce.com/abstract/nonclinical-safety-assessment-of-pf614-a-novel-taap-prodrug-of-oxycodone/ 2024-06-11T12:21:58+00:00 https://legacy.ensysce.com/abstract/first-in-man-evaluation-of-pf329/ 2024-06-11T12:22:19+00:00 https://legacy.ensysce.com/abstract/the-next-generation-opioid-products-for-moderate-severe-pain-2/ 2024-06-11T12:26:14+00:00 https://legacy.ensysce.com/abstract/morphine-withdrawal-poster/ 2026-01-28T15:29:11+00:00